Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Green

Showing results (11-20 of 155) with videos related to

Pageof 16
Sort By:
BMC Musculoskeletal Disorders|June 16, 2016
Body size from birth to middle age and the risk of hip and knee replacementBette Liu, Angela Balkwill, Jane Green, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|September 25, 2025
ADHD: overdiagnosis or opportunity?Heidi Phillips, Jessica Eccles, Helen Minnis, et al.
Journal of the National Cancer Institute|February 1, 2011
Breast cancer risk in relation to the interval between menopause and starting hormone therapyValerie Beral, Gillian Reeves, Diana Bull, et al.
International Journal of Cancer|October 22, 2014
Menopausal hormone therapy and central nervous system tumor risk: large UK prospective study and meta-analysisVictoria S Benson, Oksana Kirichek, Valerie Beral, et al.
Drugs in R&D|August 18, 2017
Methodological Study of Vancomycin Dosing in Elderly Patients Using Actual Serum Creatinine Versus Rounded Serum CreatinineTramaine Young, Matt Daniel, Stephanie Baumhover, et al.
BMC Neurology|May 8, 2012
Incidence of and risk factors for motor neurone disease in UK women: a prospective studyPat Doyle, Anna Brown, Valerie Beral, et al.
International Journal of Cancer|September 18, 2015
Tubal ligation and ovarian cancer risk in a large cohort: Substantial variation by histological typeKezia Gaitskell, Jane Green, Kirstin Pirie, et al.
Lancet (London, England)|September 21, 2002
Oral contraceptives and cervical cancerAmy Berrington, Prabhat Jha, Julian Peto, et al.
Plos Medicine|March 21, 2023
Combined and progestagen-only hormonal contraceptives and breast cancer risk: A UK nested case-control study and meta-analysisDanielle Fitzpatrick, Kirstin Pirie, Gillian Reeves, et al.
Breast Cancer Research : BCR|February 7, 2006
Breast cancer histological classification: agreement between the Office for National Statistics and the National Health Service Breast Screening ProgrammeToral Gathani, Diana Bull, Jane Green, et al.
Pageof 16

Showing results (11-20 of 155) with videos related to

Sort By:
Pageof 16
BMC Musculoskeletal Disorders|June 16, 2016
Body size from birth to middle age and the risk of hip and knee replacementBette Liu, Angela Balkwill, Jane Green, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|September 25, 2025
ADHD: overdiagnosis or opportunity?Heidi Phillips, Jessica Eccles, Helen Minnis, et al.
Journal of the National Cancer Institute|February 1, 2011
Breast cancer risk in relation to the interval between menopause and starting hormone therapyValerie Beral, Gillian Reeves, Diana Bull, et al.
International Journal of Cancer|October 22, 2014
Menopausal hormone therapy and central nervous system tumor risk: large UK prospective study and meta-analysisVictoria S Benson, Oksana Kirichek, Valerie Beral, et al.
Drugs in R&D|August 18, 2017
Methodological Study of Vancomycin Dosing in Elderly Patients Using Actual Serum Creatinine Versus Rounded Serum CreatinineTramaine Young, Matt Daniel, Stephanie Baumhover, et al.
BMC Neurology|May 8, 2012
Incidence of and risk factors for motor neurone disease in UK women: a prospective studyPat Doyle, Anna Brown, Valerie Beral, et al.
International Journal of Cancer|September 18, 2015
Tubal ligation and ovarian cancer risk in a large cohort: Substantial variation by histological typeKezia Gaitskell, Jane Green, Kirstin Pirie, et al.
Lancet (London, England)|September 21, 2002
Oral contraceptives and cervical cancerAmy Berrington, Prabhat Jha, Julian Peto, et al.
Plos Medicine|March 21, 2023
Combined and progestagen-only hormonal contraceptives and breast cancer risk: A UK nested case-control study and meta-analysisDanielle Fitzpatrick, Kirstin Pirie, Gillian Reeves, et al.
Breast Cancer Research : BCR|February 7, 2006
Breast cancer histological classification: agreement between the Office for National Statistics and the National Health Service Breast Screening ProgrammeToral Gathani, Diana Bull, Jane Green, et al.
Pageof 16